The case of methotrexate and the lung: Dr Jekyll and Mr Hyde

Vincent Cottin, Elizabeth Bendstrup, Philippe Bonniaud, Mouhamad Nasser, Paolo Spagnolo, Claudia Valenzuela, Martin Kolb

Source: Eur Respir J, 57 (2) 2100079; 10.1183/13993003.00079-2021
Journal Issue: February
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vincent Cottin, Elizabeth Bendstrup, Philippe Bonniaud, Mouhamad Nasser, Paolo Spagnolo, Claudia Valenzuela, Martin Kolb. The case of methotrexate and the lung: Dr Jekyll and Mr Hyde. Eur Respir J, 57 (2) 2100079; 10.1183/13993003.00079-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In memoriam Professor Paul Vermeire, 1936 2007: a tribute from the ERJ Chief Editors
Source: Eur Respir J 2007; 30: 819-820
Year: 2007


Introductory lecture in memoriam: Professor Philip Quanjer
Source: International Congress 2017 – Mission impossible? Implementing a whole package of new reference values for lung function
Year: 2017

“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent and David J. Jackson. ERJ Open Res 2019; 6: 00272-2019
Source: ERJ Open Res, 7 (1) 50451-2020; 10.1183/23120541.50451-2020
Year: 2021


In memoriam: Professor Philip H. Quanjer
Source: Eur Respir J, 50 (3) 1701660; 10.1183/13993003.01660-2017
Year: 2017


“A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease” Simon Bax, Charlene Bredy, Aleksander Kempny, Konstantinos Dimopoulos, Anand Devaraj, Simon Walsh, Joseph Jacob, Arjun Nair, Maria Kokosi, Gregory Keir, Vasileios Kouranos, Peter M. George, Colm McCabe, Michael Wilde, Athol Wells, Wei Li, Stephen John Wort and Laura C. Price. ERJ Open Res 2018; 4: 00124-2017.
Source: ERJ Open Res, 4 (3) 00124-2017-AUT; 10.1183/23120541.50124-2017
Year: 2018


Prof. John Guy Widdicombe, 1925–2011: an appreciation of an eminent respiratory physiologist
Source: Eur Respir J 2011; 38: 1243-1244
Year: 2011


Withdrawal notice for: “Circulating RNA differences between patients with stable and progressive lung function in IPF.” Britt Clynick, Helen E. Jo, Tamera J. Corte, Ian N. Glaspole, Christopher Grainge, Peter M.A. Hopkins, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Gregory J. Keir, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Nicole Goh, Svetlana Baltic, Marissa Ryan, Dino Tan and Yuben Moodley. Eur Respir J 2019; in press.
Source: Eur Respir J, 54 (5) 1802115; 10.1183/13993003.02115-2018
Year: 2019


“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775.
Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015
Year: 2017


“The effect of exacerbation history on outcomes in the IMPACT trial.” David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise and Gerard J. Criner. Eur Respir J 2020; 55: 1901921.
Source: Eur Respir J, 55 (6) 1951921; 10.1183/13993003.51921-2019
Year: 2020



Goodbye. Introducing the new Chief Editors: Peter Sterk and Klaus Rabe
Source: Eur Respir J 2002; 20: 1357-1358
Year: 2002


“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373.
Source: Eur Respir J 2014; 43: 1216
Year: 2014


“International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.” Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald Teague. Eur Respir J 2014; 43: 343–373.
Source: Eur Respir J, 52 (1) 1352020; 10.1183/13993003.52020-2013
Year: 2018


“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185.
Source: Eur Respir J 2016; 47:1892
Year: 2016


In memoriam Professor Dick Orie
Source: Eur Respir J 2006; 28: 891-892
Year: 2006


“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018
Year: 2018


“Advancing preparedness for clinical research during infectious disease epidemics” Nina Gobat, John Amuasi, Yazdan Yazdanpanah, Louise Sigfrid, Hugh Davies, John-Paul Byrne, Gail Carson, Christopher Butler, Alistair Nichol and Herman Goossens. ERJ Open Res 2019; 5: 00227-2018.
Source: ERJ Open Res, 5 (3) 00227-2018-AUT; 10.1183/23120541.50227-2018
Year: 2019


“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833.
Source: Eur Respir J 2016; 47: 692
Year: 2016


“The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites” Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, Felisa Reyes-Ortega, John W. Wilson, Brenda Button, Ayame Saito, Daniel P. Poole, Daniel Hoyer, Jian Li and Tony Velkov. ERJ Open Res 2018; 4: 00127-2017.
Source: ERJ Open Res, 4 (4) 00127-2017-ERR; 10.1183/23120541.50127-2017
Year: 2018